US3051621A
(en)
*
|
1959-10-22 |
1962-08-28 |
Grove Lab Inc |
Gel composition, pressurized container with same, and method of preparation
|
US3050443A
(en)
*
|
1960-02-16 |
1962-08-21 |
James F Schuyler |
Headache remedy containing ammonia
|
US3039928A
(en)
*
|
1960-03-17 |
1962-06-19 |
Abbott Lab |
Stable aqueous isoproteronol compositions
|
NL262354A
(instruction)
*
|
1960-03-17 |
|
|
|
US3088874A
(en)
*
|
1960-05-23 |
1963-05-07 |
Union Carbide Corp |
Powder aerosol
|
US3282781A
(en)
*
|
1960-11-25 |
1966-11-01 |
Merck & Co Inc |
Inhalant compositions
|
BE632504A
(instruction)
*
|
1962-05-24 |
|
|
|
US3169095A
(en)
*
|
1962-10-30 |
1965-02-09 |
Rexall Drug Chemical |
Self-propelling powder-dispensing compositions
|
NL302251A
(instruction)
*
|
1963-01-28 |
1965-10-11 |
|
|
US3710782A
(en)
*
|
1969-10-01 |
1973-01-16 |
Hauser Res And Eng Co |
Method of treating human skin with a composition for electromedical applications
|
IL51314A
(en)
*
|
1976-01-30 |
1980-03-31 |
Fisons Ltd |
Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it
|
AU522792B2
(en)
*
|
1977-07-19 |
1982-06-24 |
Fisons Plc |
Pressure pack formulation
|
US4352789A
(en)
*
|
1980-03-17 |
1982-10-05 |
Minnesota Mining And Manufacturing Company |
Aerosol compositions containing finely divided solid materials
|
US4655231A
(en)
*
|
1984-01-09 |
1987-04-07 |
Advanced Tobacco Products, Inc. |
Snuff and preparation thereof
|
US4576949A
(en)
*
|
1984-05-07 |
1986-03-18 |
The Upjohn Company |
Use of 5,6,7,8-tetrahydroquinolines and 5,6-dihydropyrindines as leukotriene and lipoxygenase inhibitors and the novel 3-substituted compounds therein
|
EP0213108A3
(de)
*
|
1985-06-26 |
1987-07-15 |
Kurt Dr. Burghart |
Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
|
JPH0645538B2
(ja)
*
|
1987-09-30 |
1994-06-15 |
日本化薬株式会社 |
ニトログリセリンスプレー剤
|
FR2625677A1
(fr)
*
|
1988-01-07 |
1989-07-13 |
Cosnier Alain |
Composition medicamenteuse destinee a etre administree sous forme d'aerosol
|
DE68915203T2
(de)
*
|
1988-03-22 |
1994-09-22 |
Fisons Plc, Ipswich, Suffolk |
Pharmazeutische Mischungen.
|
US5776434A
(en)
*
|
1988-12-06 |
1998-07-07 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
DE4003270A1
(de)
*
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
US5118494A
(en)
*
|
1990-03-23 |
1992-06-02 |
Minnesota Mining And Manufacturing Company |
Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
US5175152A
(en)
*
|
1990-09-28 |
1992-12-29 |
Singh Nikhilesh N |
Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
|
MX9203481A
(es)
*
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
US5919435A
(en)
*
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
YU59192A
(sh)
|
1991-06-10 |
1994-12-28 |
Schering Corporation |
Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
|
US5234933A
(en)
*
|
1991-10-31 |
1993-08-10 |
Board Of Governors Of Wayne State University And Vanderbilt University |
Cyclic hydroxamic acids
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US5916540A
(en)
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
US5683676A
(en)
*
|
1991-12-12 |
1997-11-04 |
Glaxo Group Limited |
Canister containing aerosol formulations containing P134a and particulate medicaments
|
DE69205177T2
(de)
*
|
1991-12-12 |
1996-03-21 |
Glaxo Group Ltd., Greenford, Middlesex |
Pharmazeutische Aerosolformulierung.
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
CA2125666C
(en)
|
1991-12-12 |
2002-07-16 |
Rachel Ann Akehurst |
Medicaments
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
ES2159678T3
(es)
|
1991-12-18 |
2001-10-16 |
Minnesota Mining & Mfg |
Formulaciones de aerosol en suspension.
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
CA2151383C
(en)
*
|
1992-12-09 |
2005-02-08 |
Paul Donald Jager |
Stabilized medicinal aerosol solution formulation
|
ES2113574T3
(es)
*
|
1993-06-01 |
1998-05-01 |
Ono Pharmaceutical Co |
Derivados del acido pentanoico.
|
EP0640609A1
(en)
*
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
CA2137106C
(en)
*
|
1993-12-03 |
2000-02-08 |
Hisao Nakai |
Amidinophenol derivatives
|
NZ276637A
(en)
*
|
1993-12-20 |
1997-07-27 |
Minnesota Mining & Mfg |
Aerosol containing flunisolide, ethanol, and tetrafluoroethane and/or heptafluoropropane propellant
|
DK0703216T3
(da)
|
1994-09-20 |
1999-10-18 |
Ono Pharmaceutical Co |
Amidinophenolderivater som proteaseinhibitorer
|
US5679287A
(en)
*
|
1995-04-28 |
1997-10-21 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
US5840213A
(en)
*
|
1995-04-28 |
1998-11-24 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
EP0757984B1
(en)
*
|
1995-08-08 |
2002-10-30 |
Ono Pharmaceutical Co., Ltd. |
Hydroxamic acid derivatives useful for inhibiting gelatinase
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US5861268A
(en)
*
|
1996-05-23 |
1999-01-19 |
Biomide Investment Limited Partnership |
Method for induction of tumor cell apoptosis with chemical inhibitors targeted to 12-lipoxygenase
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
DK1014943T3
(da)
|
1997-02-05 |
2002-10-14 |
Jago Res Ag |
Medicinske aerosolformuleringer
|
US5891420A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
US5891419A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe flunisolide aerosol formulations for oral inhalation
|
US7153866B1
(en)
*
|
1997-05-27 |
2006-12-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
JPH11187882A
(ja)
|
1997-12-26 |
1999-07-13 |
Ono Pharmaceut Co Ltd |
新規なポリペプチド、その製造方法、そのポリペプチドをコードするcDNA、そのcDNAからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
|
ES2234266T3
(es)
|
1998-07-24 |
2005-06-16 |
Jago Research Ag |
Formulaciones medicas para aerosoles.
|
DE59904648D1
(de)
|
1998-08-04 |
2003-04-24 |
Jago Res Ag Muttenz |
Medizinische aerosolformulierungen
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
US6136294C1
(en)
*
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
PL367740A1
(en)
|
2001-07-23 |
2005-03-07 |
Ono Pharmaceutical Co, Ltd. |
Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
|
NZ534712A
(en)
|
2002-02-19 |
2006-11-30 |
Ono Pharmaceutical Co |
Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
EP1534235B1
(en)
|
2002-06-25 |
2016-07-27 |
Acrux DDS Pty Ltd |
Transdermal delivery rate control using amorphous pharmaceutical compositions
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
ES2464157T3
(es)
|
2002-06-26 |
2014-05-30 |
Ono Pharmaceutical Co., Ltd. |
Remedios para enfermedades causadas por contracción o dilatación vascular
|
EP3287144A1
(en)
|
2002-07-03 |
2018-02-28 |
ONO Pharmaceutical Co., Ltd. |
Immunopotentiating compositions
|
TW200408393A
(en)
|
2002-10-03 |
2004-06-01 |
Ono Pharmaceutical Co |
Antagonist of lysophosphatidine acid receptor
|
AU2003272962A1
(en)
*
|
2002-10-10 |
2004-05-04 |
Shuh Narumiya |
Remedies for allergic diseases
|
TW200413000A
(en)
|
2002-10-10 |
2004-08-01 |
Ono Pharmaceutical Co |
Intrinsic repair factor producing accelerator
|
ES2729974T3
(es)
|
2003-01-23 |
2019-11-07 |
Ono Pharmaceutical Co |
Anticuerpo específico de PD-1 y CD3 humanas
|
BRPI0408332A
(pt)
|
2003-03-14 |
2006-03-21 |
Ono Pharmaceutical Co |
derivados heterocìclicos contendo nitrogênio e medicamentos contendo os mesmos como ingrediente ativo
|
WO2004092169A1
(ja)
|
2003-04-18 |
2004-10-28 |
Ono Pharmaceutical Co., Ltd. |
スピロピペリジン化合物およびその医薬用途
|
US20050107306A1
(en)
*
|
2003-05-16 |
2005-05-19 |
Barr Philip J. |
Treatment of respiratory disease associated with matrix metalloproteases by inhalation of synthetic matrix metalloprotease inhibitors
|
WO2006031210A1
(en)
*
|
2003-05-29 |
2006-03-23 |
Board Of Regents, The University Of Texas Systems |
Jabi as a prognostic marker and a therapeutic target for human cancer
|
US20070270489A1
(en)
|
2003-07-25 |
2007-11-22 |
Ono Pharmaceutical Co., Ltd. |
Remedy for Cartilage-Related Diseases
|
EP2883865B1
(en)
|
2003-08-29 |
2019-09-25 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
MXPA06002152A
(es)
|
2003-09-01 |
2006-05-22 |
Ono Pharmaceutical Co |
Compuesto de anillo condensado y uso del mismo.
|
JP2007505136A
(ja)
*
|
2003-09-10 |
2007-03-08 |
マツプ・フアーマシユーテイカルズ・インコーポレーテツド |
ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤
|
KR20060106823A
(ko)
*
|
2003-10-20 |
2006-10-12 |
쉐링 코포레이션 |
약제학적 에어로졸 조성물
|
EP2308562B1
(en)
|
2003-12-25 |
2015-02-25 |
Ono Pharmaceutical Co., Ltd. |
Azetidine ring compounds and drugs comprising the same
|
WO2006004646A1
(en)
*
|
2004-06-28 |
2006-01-12 |
Nektar Therapeutics |
Aerosol formulation comprising nicotine salt
|
ES2750600T3
(es)
|
2004-10-21 |
2020-03-26 |
Ono Pharmaceutical Co |
Uso de un receptor inmunosupresor
|
KR101158603B1
(ko)
*
|
2004-11-24 |
2012-07-09 |
알콘, 인코퍼레이티드 |
비강용 스프레이를 전달하는 방법
|
WO2006084041A2
(en)
|
2005-02-02 |
2006-08-10 |
Mitos Pharmaceuticals, Inc. |
Nitroxides for use in treating or preventing diabetes
|
CA2608273C
(en)
|
2005-05-18 |
2015-10-20 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US8524735B2
(en)
*
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
PL2656860T3
(pl)
|
2005-06-17 |
2021-11-08 |
Wisconsin Alumni Research Foundation |
Preparaty środka zwężającego naczynia i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej
|
WO2007049771A1
(ja)
|
2005-10-28 |
2007-05-03 |
Ono Pharmaceutical Co., Ltd. |
塩基性基を含有する化合物およびその用途
|
EP1961745A1
(en)
|
2005-12-12 |
2008-08-27 |
Ono Pharmaceutical Co., Ltd. |
Bicyclic heterocyclic compound
|
WO2007069671A1
(ja)
|
2005-12-15 |
2007-06-21 |
Ono Pharmaceutical Co., Ltd. |
二環式複素環化合物
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
CN104188907A
(zh)
|
2007-02-11 |
2014-12-10 |
Map药物公司 |
治疗性施用dhe用于快速减轻偏头痛而使副作用分布最小化的方法
|
TW200902019A
(en)
|
2007-04-26 |
2009-01-16 |
Ono Pharmaceutical Co |
Dicyclic heterocyclic compound
|
DE102008007198A1
(de)
|
2008-02-01 |
2009-08-13 |
Infectopharm Arzneimittel Und Consilium Gmbh |
Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
|
PT2346509T
(pt)
|
2008-10-07 |
2020-08-05 |
Horizon Orphan Llc |
Inalação de levofloxacina para redução da inflamação pulmonar
|
AU2009302478B2
(en)
|
2008-10-07 |
2015-09-03 |
Horizon Orphan Llc |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
TWI469965B
(zh)
|
2008-12-22 |
2015-01-21 |
Ono Pharmaceutical Co |
乙炔基吲哚化合物
|
JP5621771B2
(ja)
|
2009-06-17 |
2014-11-12 |
小野薬品工業株式会社 |
新規なイミダゾピリジン化合物
|
WO2010151804A1
(en)
*
|
2009-06-26 |
2010-12-29 |
Map Pharmaceuticals, Inc. |
Administration of dihydroergotamine mesylate particles using a metered dose inhaler
|
HUE045469T2
(hu)
|
2009-09-04 |
2019-12-30 |
Horizon Orphan Llc |
Aeroszolizált levofloxacin alkalmazása cysticus fibrosis kezelésére
|
WO2011066537A1
(en)
|
2009-11-30 |
2011-06-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc)
|
PH12012502486A1
(en)
|
2010-06-21 |
2019-07-10 |
Ono Pharmaceutical Co |
New crystalline forms of 4,4`-[4-fluoro-7-([4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl)ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid, 4,4`-[2-methyl-7-([4-[4-(pentafluorophenyl)butoxy]phenyl)ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4`-[4-fluoro-2-methyl-7-([4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl]ethynyl)-1h-indole-1,3-diyl]dibutanoic acid
|
ES2529129T3
(es)
|
2010-12-02 |
2015-02-17 |
Ono Pharmaceutical Co., Ltd. |
Nuevo compuesto y uso médico del mismo
|
WO2012106382A1
(en)
|
2011-01-31 |
2012-08-09 |
Genoa Pharmaceuticals, Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
WO2012127885A1
(ja)
|
2011-03-18 |
2012-09-27 |
小野薬品工業株式会社 |
テトラヒドロカルボリン誘導体
|
JP6160613B2
(ja)
|
2012-04-26 |
2017-07-12 |
小野薬品工業株式会社 |
Trk阻害化合物
|
WO2014129431A1
(ja)
|
2013-02-19 |
2014-08-28 |
小野薬品工業株式会社 |
Trk阻害化合物
|
CA3172586A1
(en)
|
2013-07-31 |
2015-02-05 |
Avalyn Pharma Inc. |
Aerosol imatininb compounds and uses thereof
|
JP7066321B2
(ja)
|
2014-01-10 |
2022-05-13 |
アヴァリン ファーマ インク. |
エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
|
WO2015115673A1
(en)
|
2014-01-31 |
2015-08-06 |
Ono Pharmaceutical Co., Ltd. |
Fused imidazole compounds
|
WO2018101309A1
(ja)
|
2016-11-30 |
2018-06-07 |
大日本住友製薬株式会社 |
Wt1ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ
|
US20210100886A1
(en)
|
2017-03-30 |
2021-04-08 |
Sumitomo Dainippon Pharma Co., Ltd. |
Wt1 cancer antigen peptides and peptide conjugates comprising the peptides
|
WO2019049891A1
(ja)
|
2017-09-06 |
2019-03-14 |
小野薬品工業株式会社 |
Trk阻害剤とキナーゼ阻害剤の併用による癌治療方法
|
MX2020012939A
(es)
|
2018-05-31 |
2021-02-15 |
Ono Pharmaceutical Co |
Biomarcadores para determinar la eficacia de los inhibidores de puntos de control inmunitarios.
|
TW202446772A
(zh)
|
2018-10-11 |
2024-12-01 |
日商小野藥品工業股份有限公司 |
Sting促效化合物
|
PH12022550244A1
(en)
|
2019-08-05 |
2022-12-12 |
Nat Cancer Ct |
Biomarkers for determining the efficacy of immune checkpoint inhibitors
|
US20230014137A1
(en)
|
2019-11-29 |
2023-01-19 |
Ono Pharmaceutical Co., Ltd. |
Compound having lysophosphatidic acid receptor agonist activity and pharmaceutical use thereof
|
CA3167312A1
(en)
|
2020-02-07 |
2021-08-12 |
Stephen J. Lewis |
Compositions and methods for attenuating opioid induced cardio and/or respiratory depression
|
WO2021205631A1
(ja)
|
2020-04-10 |
2021-10-14 |
小野薬品工業株式会社 |
Sting作動化合物
|
US20230183316A1
(en)
|
2020-05-12 |
2023-06-15 |
Sumitomo Pharma Co., Ltd. |
Pharmaceutical composition for treating cancer
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
WO2022251679A1
(en)
|
2021-05-27 |
2022-12-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide radicals for use as antiviral treatment for coronavirus infection
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|